• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov14
NRX Pharmaceuticals released FY2025 Q3 earnings on November 14 Pre-Market (EST), actual revenue USD 242K (forecast USD 6.075M), actual EPS USD -0.2699 (forecast USD -0.0325)
14:30
NRX Pharmaceuticals released FY2025 9-month earnings on November 14 Pre-Market EST, actual revenue USD 242 K, actual EPS USD -1.5861
14:30
Nov10
NRX Pharmaceuticals to Release FY2025 Q3 Earnings on November 17, Pre-Market EST; Forecast Revenue USD 6.075 M, EPS USD -0.0325
00:05
Oct6
Background introduction of NRx Pharmaceuticals and HOPE Therapeutics
13:02
Sep29
KETAFREE™ Provides Non-Preservative Intravenous Ketamine Formula
13:03
Sep26
NRX Pharmaceuticals Receives FDA Approval for New Drug Formulation
12:02

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 242 K, Net Income -5.89 M, EPS -0.2699

Aug18
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -17.58 M, EPS -0.9803

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.512 M, EPS -0.3358

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0493
+77.34%
+0.021
FOXX
3.540
+75.16%
+1.519
PTN
22.820
+57.49%
+8.330
MNDR
4.750
+56.25%
+1.710
NVVE
0.2558
+55.88%
+0.092
DVLT
2.550
+46.55%
+0.810
CCTG
0.2364
+43.01%
+0.071
IVDA
0.8760
+34.67%
+0.226
BLMZ
1.000
+30.55%
+0.234
ALPS
1.180
+29.56%
+0.269
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy